•  
  •  
 

Instructions to Authors

Manuscript requirements

Please prepare your manuscript before submission, using the following guidelines. Failure to follow our guidelines will result in the ‘unsubmission’ of your manuscript.

Language

The manuscript is written in academic English. For non-native English speakers, a certificate of English editing from an authorized language institute or from a qualified and certified individual linguistic editor is needed.

Article length (excluding abstract and references):

  • Original research articles: should be no longer than 4000 words
  • Review articles: should be no longer than 5000 words
  • Short report: should be no longer than 2000 words
  • Commentaries: should be no longer than 1500 words

Format:

Manuscript files should be provided in Microsoft Word format with continuing line number enabled.

Cover letter:

Cover is required by Journal of Health Research. The author should summarize their work, especially the significance of the study.

Title page/Author details:

All authors should be listed using first name, initials, last name and academic affiliation. The corresponding author should be specified only one person, and an address for correspondence (usually an e-mail address) should be given. This title page should be separately uploaded in the submission system.

  • Correct e-mail addresses should be supplied for each author in their separate author accounts
  • The full name of each author must be present in their author account in the exact format they should appear for publication, including or excluding any middle names or initials as required
  • The affiliation of each contributing author should be correct in their individual author account. The affiliation listed should be where they were based at the time that the research for the paper was conducted

Content Organization

Article title: Title must be concise. clear, informative and containing population and the location of study and outcome. Experimental studies' titles must refer to the intervention and control group, if any. Within the imposed limits, optional words may include study design and any words that could make the title attractive/captivating. Titles with more than 100 characters are not prohibited.

Structured abstract: Authors must supply a structured abstract. Maximum is 250 words in total (including keywords).

  • Background
  • Method
  • Results
  • Conclusion
  • Keywords (not more than 6 words or phrases in alphabetical order)

Introduction: The introduction should establish the objectives, relevance and significance of the research and provide a framework for the manuscript.

Methodology: Sufficient details should be provided to describe and justify the method of the study such as study design, study areas, target population, sample size determination, sampling techniques, research instruments, validity and reliability test of instruments, data collection procedures and data analyses. Ethical declaration should be mentioned in this part (apply for review / systematic review paper). For the RCT and clinical trial study, please include the Clinical Trial Registration number and registry name in this section.

Results: The results section needs to be clearly and concisely stated according to the research question comprising new knowledge contributed. Authors present representative data or their description and avoid redundancy. The results section should be presented using the past tense.

Tables and Figures: Should be placed in body of text in MS Word format. Each table or figure should be numbered consecutively with a brief title for each but place explanatory matter in a footnote below the table or figure. Please allow 260 words for each figure or table, a maximum of 6 tables and figures. Figure resolution should be at least 300 dpi.

Discussion: The authors explain and comment on whether or not the results were expected for each set of results, and explain their meaning in relation to the stated research problem. The authors should compare the results of their study with results of related studies. The limitations or strengths of the study are usually listed in the final paragraph of the discussion.

Conclusions: The author should summarize what you’ve written about in your paper especially the key points of the paper.

Recommendations: The author should address limitations, implication and suggest how they might be overcome in future work/practices.

Acknowledgement: Acknowledgement of persons or organizations.

Funding: All funding sources must be mentioned, including funding organizations and numbers of grants and other vehicles of funding.

Conflict of interest: Should be mentioned and placed before reference section.

Appendix: Supplementary information (with a large file) should be hosted in instructional repository and presented a URL or make a link in an appendix before the reference section.

References and in-text citation: The Vancouver style reference format should be followed. In-text citations are to be numbered consecutively in parentheses. In the reference list, citations should be given in the same numbered in parentheses order as in the text. All authors should be quoted for papers with up to six authors, and for papers with more than six authors, the first six should be quoted followed by “et al.” Periodical (Journal) abbreviations should follow those used by PubMed. Some examples of how to quote references are given below.

Journal article

  • [1]. Kwan I, Mapstone J. Visibility aids for pedestrians and cyclists: a systematic review of randomised controlled trials. Accid Anal Prev. 2004; 36(3): 305-12.
  • [2]. Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002 May; 935(1-2): 40-6.
  • [3]. Montero D, Roche E, Martinez-Rodriguez A. The impact of aerobic exercise training on arterial stiffness in pre- and hypertensive subjects: a systematic review and meta-analysis. Int J Cardiol. 2014 May; 173(3): 361-8. doi: 10.1016/j.ijcard.2014.03.072

Entire book

[1]. Miles DA, Van Dis ML, Williamson GF, Jensen CW. Radiographic imaging for the dental team. 4th ed. St. Louis: Saunders Elsevier; 2009.

Book chapter

[1]. Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p.93-113.

Electronic journal article (The most recent date of access must be given):

[1]. Stone D, Harper BJ, Lynch I, Dawson K, Harper SL. Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health. 2010 Oct-Dec; 16(4): 467-74 [cited 2010 Jan 10]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21222390

Electronic book/monograph on the Internet:

[1]. Donaldson MS, editor. Measuring the quality of health care [monograph on the internet]. Washington: National Academy Press; 1999 [cited 2004 Oct 8]. Available from: http://legacy.netlibrary.com/

Proceedings article:

[1]. Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, editors. Genetic programming. EuroGP: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Berlin: Springer; 2002. p.182-91.

Website [updated = Last Update Date; cited = Access Year Access Date]:

[1]. National Cancer Institute. Fact sheet: targeted cancer therapies. [updated: 2014 April 25; cited 2014 June 2]. Available from: http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#q1

Confirm the following:

  • The manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere.
  • All the research meets the ethical guidelines and international standards of reporting, including adherence to the legal requirements of the study country.
  • Author have prepared the Clinical Trial Registration number and registry name for the RCT and clinical trial study.
  • Author have prepared a complete text within the anonymous article file. Any identifying information has been included separately in a title page or supplementary file not for review, to allow double-blinded review.
  • Author have declared any potential conflict of interest in the research.
  • Any support from a third party has been noted in the Acknowledgements.
  • For non-native English speakers, a certificate of English editing from an authorized language institute or from a qualified and certified individual linguistic editor is needed.

Revising and responding manuscript:

Author will be unable to make your revisions on the originally submitted version of the manuscript. Instead, revise your manuscript using a word processing program and save it on your computer. Please also highlight the changes to your manuscript within the document by using the track changes mode in MS Word or by using bold or coloured text. Link your revised text to each of the reviewer’s comments. Please, include in the ‘comment bubbles’ ALL the comments made by reviewer # 1 or # 2. ‘Cut and paste’ ONE BY ONE the reviewer comments your addressing in the bubble and link it to the manuscript change that addresses that specific comment.

By ALL comments we mean every request for change starting from the reviewer’s section ‘Background to ‘Conclusion'. If author have not addressed some of the reviewers’ comments in your manuscript, please, add a note at the end of it (delete 'your revised manuscript') with quotes of the not addressed reviewers’ comments and for each of them, please, provide a justification.

Two versions of the revised manuscript must be uploaded:one clean copy and one with the changes indicated by the “Track Changes” function.